CD86 and hematocrit: Patients with HT were also characterized by an increased frequency of CD86+ non-classical Mo, which has been previously reported in patients with other autoimmune diseases including multiple sclerosis (37), systemic lupus erythematous (38), and primary biliary cirrhosis (39).